{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:31:18Z","timestamp":1768987878661,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,25]]},"DOI":"10.7759\/cureus.32940","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T04:16:36Z","timestamp":1672028196000},"source":"Crossref","is-referenced-by-count":1,"title":["A Comparison of Intensity-Modulated Radiotherapy With Simultaneous Integrated Boost With Three-Dimensional Conformal Radiotherapy With Sequential Boost for Locally Advanced Cervical Cancer: A Dosimetric Study"],"prefix":"10.7759","author":[{"given":"Carlos Ivan","family":"Figueredo Negron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Gamboa Garay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Pab\u00f3n Gir\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Alejandro","family":"Esguerra Cantillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Guerrero Lizcano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication","volume":"128","author":"Li N","year":"2011","unstructured":"Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer. 2011, 128:927-35. 10.1002\/ijc.25396","journal-title":"Int J Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.07.197","article-title":"Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01","volume":"22","author":"Eifel PJ","year":"2004","unstructured":"Eifel PJ, Winter K, Morris M, et al.. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004, 22:872-80. 10.1200\/JCO.2004.07.197","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05965-7","article-title":"Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis","volume":"358","author":"Green JA","year":"2001","unstructured":"Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, Willians CJ. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001, 358:781-6. 10.1016\/S0140-6736(01)05965-7","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.5.1339","article-title":"Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study","volume":"17","author":"Whitney CW","year":"1999","unstructured":"Whitney CW, Sause W, Bundy BN, et al.. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999, 17:1339-48. 10.1200\/JCO.1999.17.5.1339","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2020.04.002","article-title":"Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline","volume":"10","author":"Chino J","year":"2020","unstructured":"Chino J, Annunziata CM, Beriwal S, et al.. Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline. Pract Radiat Oncol. 2020, 10:220-34. 10.1016\/j.prro.2020.04.002","journal-title":"Pract Radiat Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-018-2362-9","article-title":"The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology guidelines for the management of patients with cervical cancer","volume":"472","author":"Cibula D","year":"2018","unstructured":"Cibula D, P\u00f6tter R, Planchamp F, et al.. The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology guidelines for the management of patients with cervical cancer. Virchows Arch. 2018, 472:919-36. 10.1007\/s00428-018-2362-9","journal-title":"Virchows Arch"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx220","article-title":"Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Marth C","year":"2017","unstructured":"Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017, 28:iv72-83. 10.1093\/annonc\/mdx220","journal-title":"Ann Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(93)90522-w","article-title":"Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome","volume":"27","author":"Girinsky T","year":"1993","unstructured":"Girinsky T, Rey A, Roche B, Haie C, Gerbaulet A, Randrianarivello H, Chassagne D. Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys. 1993, 27:1051-6. 10.1016\/0360-3016(93)90522-w","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(95)00220-S","article-title":"Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy","volume":"32","author":"Perez CA","year":"1995","unstructured":"Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys. 1995, 32:1275-88. 10.1016\/0360-3016(95)00220-S","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2016.05.014","article-title":"Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer","volume":"120","author":"Tanderup K","year":"2016","unstructured":"Tanderup K, Fokdal LU, Sturdza A, et al.. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. Radiother Oncol. 2016, 120:441-6. 10.1016\/j.radonc.2016.05.014","journal-title":"Radiother Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19617","article-title":"The prognostic impact of overall treatment time on disease outcome in uterine cervical cancer patients treated primarily with concomitant chemoradiotherapy: a nationwide Taiwanese cohort study","volume":"8","author":"Lin SM","year":"2017","unstructured":"Lin SM, Ku HY, Chang TC, Liu TW, Hong JH. The prognostic impact of overall treatment time on disease outcome in uterine cervical cancer patients treated primarily with concomitant chemoradiotherapy: a nationwide Taiwanese cohort study. Oncotarget. 2017, 8:85203-13. 10.18632\/oncotarget.19617","journal-title":"Oncotarget"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.05.031","article-title":"Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer","volume":"79","author":"Fenkell L","year":"2011","unstructured":"Fenkell L, Assenholt M, Nielsen SK, Haie-Meder C, P\u00f6tter R, Lindegaard J, Tanderup K. Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2011, 79:1572-9. 10.1016\/j.ijrobp.2010.05.031","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.11.027","article-title":"Bone marrow-sparing intensity modulated radiation therapy with concurrent cisplatin for stage IB-Iva cervical cancer: an international multicenter phase II clinical trial (INTERTECC-2)","volume":"97","author":"Mell LK","year":"2017","unstructured":"Mell LK, Sir\u00e1k I, Wei L, et al.. Bone marrow-sparing intensity modulated radiation therapy with concurrent cisplatin for stage IB-Iva cervical cancer: an international multicenter phase II clinical trial (INTERTECC-2). Int J Radiat Oncol Biol Phys. 2017, 97:536-45. 10.1016\/j.ijrobp.2016.11.027","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02381","article-title":"Improvement in patient-reported outcomes with intensity-modulated radiotherapy (RT) compared with standard RT: a report from the NRG Oncology RTOG 1203 study","volume":"38","author":"Yeung AR","year":"2020","unstructured":"Yeung AR, Pugh SL, Klopp AH, et al.. Improvement in patient-reported outcomes with intensity-modulated radiotherapy (RT) compared with standard RT: a report from the NRG Oncology RTOG 1203 study. J Clin Oncol. 2020, 38:1685-92. 10.1200\/JCO.19.02381","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0958-3947(02)00101-2","article-title":"Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancer","volume":"27","author":"Schefter TE","year":"2002","unstructured":"Schefter TE, Kavanagh BD, Wu Q, et al.. Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancer. Med Dosim. 2002, 27:177-84. 10.1016\/s0958-3947(02)00101-2","journal-title":"Med Dosim"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2004.11.040","article-title":"Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations","volume":"62","author":"Guerrero M","year":"2005","unstructured":"Guerrero M, Li XA, Ma L, Linder J, Deyoung C, Erickson B. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations. Int J Radiat Oncol Biol Phys. 2005, 62:933-9. 10.1016\/j.ijrobp.2004.11.040","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20160526","article-title":"Simultaneous integrated boost (SIB) of the parametrium and cervix in radiotherapy for uterine cervical carcinoma: a dosimetric study using a new alternative approach","volume":"89","author":"Cheng JY","year":"2016","unstructured":"Cheng JY, Huang EY, Hsu SN, Wang CJ. Simultaneous integrated boost (SIB) of the parametrium and cervix in radiotherapy for uterine cervical carcinoma: a dosimetric study using a new alternative approach. Br J Radiol. 2016, 89:20160526. 10.1259\/bjr.20160526","journal-title":"Br J Radiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1120\/jacmp.v17i5.6123","article-title":"Simultaneously integrated boost (SIB) spares OAR and reduces treatment time in locally advanced cervical cancer","volume":"17","author":"Feng CH","year":"2016","unstructured":"Feng CH, Hasan Y, Kopec M, Al-Hallaq HA. Simultaneously integrated boost (SIB) spares OAR and reduces treatment time in locally advanced cervical cancer. J Appl Clin Med Phys. 2016, 17:76-89. 10.1120\/jacmp.v17i5.6123","journal-title":"J Appl Clin Med Phys"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmp.2020.04.012","article-title":"Dosimetric and radiobiological comparison of simultaneous integrated boost and sequential boost of locally advanced cervical cancer","volume":"73","author":"Sukhikh ES","year":"2020","unstructured":"Sukhikh ES, Sukhikh LG, Lushnikova PA, Tatarchenko MA, Abdelrahman AR. Dosimetric and radiobiological comparison of simultaneous integrated boost and sequential boost of locally advanced cervical cancer. Phys Med. 2020, 73:83-8. 10.1016\/j.ejmp.2020.04.012","journal-title":"Phys Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2000.93.supplement","article-title":"Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the gamma knife: early experience with brain tumors. Technical note","volume":"93","author":"Levivier M","year":"2000","unstructured":"Levivier M, Wikier D, Goldman S, et al.. Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the gamma knife: early experience with brain tumors. Technical note. J Neurosurg. 2000, 93:233-8. 10.3171\/jns.2000.93.supplement","journal-title":"J Neurosurg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.09.028","article-title":"Conformity index: a review","volume":"64","author":"Feuvret L","year":"2006","unstructured":"Feuvret L, No\u00ebl G, Mazeron JJ, Bey P. Conformity index: a review. Int J Radiat Oncol Biol Phys. 2006, 64:333-42. 10.1016\/j.ijrobp.2005.09.028","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/jicru\/ndq004","article-title":"","author":"International Commission on Radiation Units and Measurements","year":"2010","unstructured":"International Commission on Radiation Units and Measurements. ICRU Report 83 prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT). Oxford University Press, Oxford, England; 2010. 10.1093\/jicru\/ndq004"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.meddos.2017.05.002","article-title":"Simultaneous integrated boost (SIB) for treatment of gynecologic carcinoma: intensity-modulated radiation therapy (IMRT) vs volumetric-modulated arc therapy (VMAT) radiotherapy","volume":"42","author":"Vergalasova I","year":"2017","unstructured":"Vergalasova I, Light K, Chino J, Craciunescu O. Simultaneous integrated boost (SIB) for treatment of gynecologic carcinoma: intensity-modulated radiation therapy (IMRT) vs volumetric-modulated arc therapy (VMAT) radiotherapy. Med Dosim. 2017, 42:230-7. 10.1016\/j.meddos.2017.05.002","journal-title":"Med Dosim"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.06.1285","article-title":"IDEAL-GYN (Integrated Dose Escalation for Advanced Localized Gynecologic Cancers): a dose escalation trial of bowel sparing simultaneous integrated boosts for node positive cervical and vulvar cancers","volume":"99","author":"Chino JP","year":"2017","unstructured":"Chino JP, Dorth JA, Suneja G, Rodrigues A, Light K, Craciunescu OI. IDEAL-GYN (Integrated Dose Escalation for Advanced Localized Gynecologic Cancers): a dose escalation trial of bowel sparing simultaneous integrated boosts for node positive cervical and vulvar cancers. Int J Radiat Oncol Biol Phys. 2017, 99:286. 10.1016\/j.ijrobp.2017.06.1285","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-016-0612-z","article-title":"Short-course PET based simultaneous integrated boost for locally advanced cervical cancer","volume":"11","author":"Arnesen MR","year":"2016","unstructured":"Arnesen MR, Rekstad BL, Stokke C, Bruheim K, L\u00f8ndalen AM, Hellebust TP, Malinen E. Short-course PET based simultaneous integrated boost for locally advanced cervical cancer. Radiat Oncol. 2016, 11:39. 10.1186\/s13014-016-0612-z","journal-title":"Radiat Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/126723-a-comparison-of-intensity-modulated-radiotherapy-with-simultaneous-integrated-boost-with-three-dimensional-conformal-radiotherapy-with-sequential-boost-for-locally-advanced-cervical-cancer-a-dosimetric-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:03Z","timestamp":1707508083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/126723-a-comparison-of-intensity-modulated-radiotherapy-with-simultaneous-integrated-boost-with-three-dimensional-conformal-radiotherapy-with-sequential-boost-for-locally-advanced-cervical-cancer-a-dosimetric-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,25]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.32940","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,25]]}}}